Replies to post #3230 on Spectrum Pharmaceutecals Inc (SPPI)

[dcaf7]

Yes, Poziotinib works. But toxicity issues are real. For any company who is thinking buy it, you need to consider a necessary phase 3 trial and competition. I can see a few drugs in clinical trials that can potentially work as Pozi but less toxic. Will be interesting to see Pyrotinib data.